Liquid Biopsy: Current Status and Future Perspectives

Article Properties
Abstract
Cite
Mader, Sonja, and Klaus Pantel. “Liquid Biopsy: Current Status and Future Perspectives”. Oncology Research and Treatment, vol. 40, no. 7-8, 2017, pp. 404-8, https://doi.org/10.1159/000478018.
Mader, S., & Pantel, K. (2017). Liquid Biopsy: Current Status and Future Perspectives. Oncology Research and Treatment, 40(7-8), 404-408. https://doi.org/10.1159/000478018
Mader, Sonja, and Klaus Pantel. “Liquid Biopsy: Current Status and Future Perspectives”. Oncology Research and Treatment 40, no. 7-8 (2017): 404-8. https://doi.org/10.1159/000478018.
Mader S, Pantel K. Liquid Biopsy: Current Status and Future Perspectives. Oncology Research and Treatment. 2017;40(7-8):404-8.
Journal Categories
Medicine
Internal medicine
Neoplasms
Tumors
Oncology
Including cancer and carcinogens
Medicine
Medicine (General)
Citations
Title Journal Journal Categories Citations Publication Date
Potential molecular biomarkers for the diagnosis and prognosis of bladder cancer Biomedicine & Pharmacotherapy
  • Medicine: Medicine (General)
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
 2024
Molecular analyses of exosome-derived miRNAs revealed reduced expression of miR-184-3p and decreased exosome concentration in patients with alveolar echinococcosis Experimental Parasitology
  • Science: Microbiology
  • Medicine: Internal medicine: Infectious and parasitic diseases
 2024
A pipeline for the development and analysis of extracellular vesicle-based transcriptomic biomarkers in molecular diagnostics Molecular Aspects of Medicine
  • Science: Biology (General)
  • Medicine: Medicine (General)
  • Medicine: Medicine (General): Medical technology
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
 2024
IDH1 mutation is detectable in plasma cell-free DNA and is associated with survival outcome in glioma patients

 BMC Cancer
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Medicine (General)
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
 2024
HCMMD: systematic evaluation of metabolites in body fluids as liquid biopsy biomarker for human cancers Aging 2024
Citations Analysis
Category Category Repetition
Medicine: Medicine (General)72
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens41
Science: Biology (General)27
Science: Chemistry: Organic chemistry: Biochemistry18
Medicine: Medicine (General): Medical technology12
Science: Biology (General): Genetics12
Science: Chemistry11
Medicine11
Medicine: Therapeutics. Pharmacology11
Science: Chemistry: Analytical chemistry10
Medicine: Public aspects of medicine: Toxicology. Poisons10
Science: Chemistry: General. Including alchemy7
Science7
Medicine: Internal medicine6
Technology: Chemical technology6
Science: Science (General)5
Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine5
Technology: Chemical technology: Biotechnology5
Science: Biology (General): Cytology5
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology5
Science: Physics4
Science: Microbiology3
Agriculture: Animal culture: Veterinary medicine2
Science: Physics: Optics. Light2
Science: Physics: Acoustics. Sound2
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry2
Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy2
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs2
Technology: Engineering (General). Civil engineering (General)2
Science: Mathematics: Instruments and machines2
Medicine: Ophthalmology2
Medicine: Internal medicine: Infectious and parasitic diseases2
Medicine: Pathology2
Medicine: Gynecology and obstetrics2
Medicine: Medicine (General): Computer applications to medicine. Medical informatics2
Science: Chemistry: Organic chemistry1
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology1
Agriculture: Plant culture1
Agriculture: Animal culture1
Technology: Electrical engineering. Electronics. Nuclear engineering: Materials of engineering and construction. Mechanics of materials1
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system1
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system1
Medicine: Internal medicine: Special situations and conditions: Geriatrics1
Technology: Mechanical engineering and machinery1
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the genitourinary system. Urology1
Science: Zoology1
Medicine: Dermatology1
Medicine: Surgery1
Medicine: Dentistry1
Medicine: Public aspects of medicine1
Medicine: Nursing1
The category Medicine: Medicine (General) 72 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Circulating cell‐free high mobility group AT‐hook 2 mRNA as a detection marker in the serum of colorectal cancer patients and was published in 2017. The most recent citation comes from a 2024 study titled HCMMD: systematic evaluation of metabolites in body fluids as liquid biopsy biomarker for human cancers. This article reached its peak citation in 2022, with 40 citations. It has been cited in 115 different journals, 33% of which are open access. Among related journals, the Cancers cited this research the most, with 13 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year